Does a higher AA/EPA ratio reflect a pro-inflammatory lipid imbalance?

The relationship between omega-6 and omega-3 fatty acids is a critical determinant of systemic inflammatory pathways. The ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) serves as an indicator of this balance, reflecting the body's baseline lipid-mediated inflammatory potential.

Biochemical mechanisms of substrate competition

• Enzymatic competition: AA and EPA compete directly for the same metabolic pathway enzymes, specifically cyclooxygenase (COX) and lipoxygenase (LOX).
• Eicosanoid synthesis: A high AA/EPA ratio reduces EPA-mediated competitive inhibition of COX. This substrate dominance drives the preferential synthesis of highly active pro-inflammatory eicosanoids, such as prostaglandin $\text{E}_2$ ($\text{PGE}_2$) and leukotriene $\text{B}_4$ ($\text{LTB}_4$).
• Pro-resolving mediators: Conversely, a lower ratio allows EPA to successfully compete for COX and LOX enzymes, yielding less-inflammatory eicosanoid analogues and specialized pro-resolving lipid mediators (SPMs) that actively limit tissue inflammation.

Membrane dynamics and omega-3 status

• Membrane displacement: The Omega-3 Index (the percentage of EPA and DHA in red blood cell membranes) directly modulates this relationship. Increased incorporation of omega-3 fatty acids into phospholipid bilayers physically displaces AA, subsequently lowering the circulating AA/EPA ratio.
• Relative substrate imbalance: A localized substrate imbalance can plausibly exist even when overall omega-3 levels appear adequate. If absolute AA levels remain disproportionately elevated, the enzyme-proximal environment will continue to favor pro-inflammatory signaling pathways despite sufficient total omega-3 tissue status.

Bottom line

• The AA/EPA ratio is a physiologically sound marker of inflammatory balance governed by enzymatic competition. A high ratio shifts lipid metabolism toward pro-inflammatory eicosanoid production, a state that can persist even when total omega-3 status is adequate if arachidonic acid levels remain disproportionately high.